Peer-reviewed veterinary case report
Surgical outcomes for dogs with soft tissue sarcoma near
By Paulos, Patrisha E et al.·Published in Veterinary and comparative oncology·2022·Mississauga-Oakville Veterinary Emergency Hospital, Canada·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study.
- Species:
- dog
Plain-English summary
A group of dogs with soft tissue sarcomas (STS) near the ischiatic tuberosity underwent surgery to remove the tumors. The study included 52 dogs, and the results showed that those with lower-grade tumors had better outcomes, while higher-grade tumors had a shorter survival time. Dogs that had their tumors completely removed had a longer time before the cancer came back compared to those with incomplete removal. Although 25% of the dogs experienced surgical complications, none of these complications led to serious health issues. Overall, the prognosis depended on the tumor's grade and whether the surgical margins were clear.
People also search for: dog soft tissue sarcoma treatment · dog surgery recovery time · what to expect after dog tumor removal
Abstract
The aim of this study was to determine the outcome of dogs with soft tissue sarcoma (STS) within the region of the ischiatic tuberosity (ITSTS) treated surgically. This was a multi-institutional retrospective study. Fifty-two dogs met the inclusion criteria, which were: histologically confirmed STS in the region of the IT treated with surgical resection between March 1st, 2009 and March 1st, 2021 with a minimum follow-up time of 6 months. Data collected included patient signalment, preoperative diagnostics, surgical intent/method, surgical complications, histopathology, margins, outcome and cause of death. Statistical analyses were performed to determine significant factors in the treatment and prognosis of ITSTS. Overall survival time (OST) and disease progression were negatively associated with tumour grade, while recurrence was positively associated with grade and incomplete margins. Of the 52 included dogs, there were 24 grade I, 20 grade II and 7 grade III tumours. Forty dogs had reported histopathologic margins of which 26 were reported to be complete and 14 were incomplete. OST and progression-free survival was not reached for tumours graded as I or II and was 255 and 268 days respectively, for grade III. Median time to recurrence was not reached for tumours excised with complete margins and was 398 days for those with incomplete margins. The surgical complication rate was 25%. ITSTS was not found to be a unique clinical entity in dogs as tumour behavior, treatment recommendations, and prognosis were similar to STS in other locations, with overall outcome and prognosis influenced by histologic grade and margins. While surgical complications were common, none resulted in significant morbidity or mortality.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35420253/